Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051403
Filing Date
2020-11-05
Accepted
2020-11-05 16:42:27
Documents
79
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kdny-10q_20200930.htm   iXBRL 10-Q 3447773
2 EX-10.8 kdny-ex108_287.htm EX-10.8 210912
3 EX-10.9 kdny-ex109_288.htm EX-10.9 295838
4 EX-31.1 kdny-ex311_7.htm EX-31.1 22164
5 EX-32.1 kdny-ex321_8.htm EX-32.1 6966
  Complete submission text file 0001564590-20-051403.txt   11782598

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kdny-20200930.xsd EX-101.SCH 65012
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kdny-20200930_cal.xml EX-101.CAL 72049
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kdny-20200930_def.xml EX-101.DEF 211972
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20200930_lab.xml EX-101.LAB 527301
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20200930_pre.xml EX-101.PRE 396085
11 EXTRACTED XBRL INSTANCE DOCUMENT kdny-10q_20200930_htm.xml XML 2176393
Mailing Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 201291184
SIC: 2834 Pharmaceutical Preparations